Susan Yung Selected Research

Autoimmune Diseases (Autoimmune Disease)

10/2015	Epigenetic dynamics in immunity and autoimmunity.
9/2015	Increased expression of TLR2 in CD4(+) T cells from SLE patients enhances immune reactivity and promotes IL-17 expression through histone modifications.
5/2015	The effect of mycophenolic acid on epigenetic modifications in lupus CD4+T cells.
1/2015	The role of microRNA-1246 in the regulation of B cell activation and the pathogenesis of systemic lupus erythematosus.
1/2015	Mechanisms of Kidney Injury in Lupus Nephritis - the Role of Anti-dsDNA Antibodies.
3/2013	E4BP4 overexpression: a protective mechanism in CD4+ T cells from SLE patients.
9/2008	Rapamycin attenuates the severity of established nephritis in lupus-prone NZB/W F1 mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Susan Yung Research Topics

Disease

25	Lupus Nephritis 01/2022 - 05/2002
15	Fibrosis (Cirrhosis) 01/2022 - 06/2007
15	Inflammation (Inflammations) 06/2021 - 11/2005
11	Neoplasms (Cancer) 01/2019 - 03/2006
8	Nephritis 01/2022 - 09/2008
8	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2016 - 05/2002
7	Autoimmune Diseases (Autoimmune Disease) 10/2015 - 09/2008
6	Proteinuria 06/2021 - 01/2009
6	Infections 01/2020 - 03/2006
5	Peritoneal Fibrosis 02/2020 - 12/2003
5	Neoplasm Metastasis (Metastasis) 01/2019 - 07/2007
4	Peritonitis 02/2020 - 07/2007
4	Ovarian Neoplasms (Ovarian Cancer) 01/2018 - 01/2013
4	Hepatitis B 09/2014 - 09/2009
3	Atrophy 01/2022 - 01/2015
3	Albuminuria 01/2021 - 09/2008
3	Diabetic Nephropathies (Diabetic Nephropathy) 01/2014 - 06/2006
2	Hyperglycemia 01/2021 - 01/2014
2	Chronic Renal Insufficiency 01/2021 - 01/2021
2	Virus Diseases (Viral Diseases) 01/2019 - 02/2007
2	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 10/2015 - 01/2014
1	Necrosis 06/2021
1	COVID-19 01/2021
1	Type 2 Diabetes Mellitus (MODY) 01/2021
1	Ureteral Obstruction 01/2021
1	Dyslipidemias (Dyslipidemia) 01/2021
1	Anemia 01/2020
1	Hypertrophy 01/2018
1	Kidney Diseases (Kidney Disease) 01/2018
1	Autosomal Dominant Polycystic Kidney (ADPKD) 01/2018
1	Pathologic Processes 12/2017

Drug/Important Bio-Agent (IBA)

11	anti-dsDNA autoantibodyIBA 06/2021 - 09/2008
8	Proteins (Proteins, Gene)FDA Link 01/2022 - 12/2003
7	Immunoglobulin G (IgG)IBA 01/2019 - 11/2005
6	Fibronectins (Fibronectin)IBA 01/2022 - 07/2009
6	Interleukin-6 (Interleukin 6)IBA 01/2022 - 11/2005
6	Sirolimus (Rapamycin)FDA Link 01/2022 - 10/2006
6	Hyaluronic Acid (Hyaluronan)IBA 06/2021 - 01/2011
6	CytokinesIBA 02/2020 - 11/2005
6	Mycophenolic Acid (Cellcept)FDA LinkGeneric 01/2020 - 01/2015
5	DNA (Deoxyribonucleic Acid)IBA 01/2019 - 05/2002
5	AutoantibodiesIBA 12/2017 - 01/2012
5	Antigen-Antibody Complex (Immune Complex)IBA 12/2017 - 01/2013
4	AntigensIBA 01/2020 - 12/2012
4	Antinuclear AntibodiesIBA 07/2009 - 05/2002
3	CollagenIBA 01/2022 - 01/2015
3	Dialysis SolutionsIBA 02/2020 - 12/2012
3	MicroRNAs (MicroRNA)IBA 09/2019 - 01/2015
3	Inflammation MediatorsIBA 04/2017 - 01/2012
3	AntibodiesIBA 01/2015 - 02/2008
3	entecavir FDA Link 09/2014 - 03/2010
3	GlycosaminoglycansIBA 01/2013 - 06/2007
3	Lamivudine (Epivir)FDA Link 08/2010 - 09/2009
2	Syndecan-1 (Syndecan 1)IBA 06/2021 - 01/2021
2	CreatinineIBA 06/2021 - 01/2021
2	ThrombomodulinIBA 06/2021 - 01/2021
2	Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA 06/2021 - 03/2015
2	DecorinIBA 02/2020 - 03/2015
2	P-SelectinIBA 01/2019 - 03/2015
2	Calcineurin InhibitorsIBA 10/2018 - 01/2018
2	Small Interfering RNA (siRNA)IBA 01/2018 - 01/2013
2	70-kDa Ribosomal Protein S6 Kinases (Ribosomal Protein S6 Kinases, 70 kDa)IBA 01/2018 - 10/2014
2	Immunoglobulins (Immunoglobulin)IBA 04/2017 - 05/2002
2	Annexin A2 (Annexin II)IBA 04/2017 - 11/2010
2	Histones (Histone)IBA 04/2017 - 10/2015
2	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2017 - 01/2015
2	AdiponectinIBA 03/2015 - 12/2012
2	Glucose (Dextrose)FDA LinkGeneric 03/2015 - 12/2003
2	ChromatinIBA 01/2015 - 02/2008
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2015 - 01/2015
2	Cadherins (E-Cadherin)IBA 10/2014 - 01/2013
2	IntegrinsIBA 10/2014 - 01/2013
2	Streptozocin (Streptozotocin)FDA Link 01/2014 - 01/2013
2	adefovirIBA 08/2010 - 03/2010
2	Transforming Growth Factor beta1 (TGF beta 1)IBA 07/2009 - 06/2007
2	Proteoglycans (Proteoglycan)IBA 07/2007 - 06/2007
1	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 06/2021
1	Glucagon-Like Peptide 1 (GLP 1)IBA 01/2021
1	dulaglutideIBA 01/2021
1	salicylhydroxamic acid (SHAM)IBA 01/2021
1	Glucagon-Like Peptide-1 Receptor AgonistsIBA 01/2021
1	Complement C3 (C3 Complement)IBA 01/2021
1	Angiotensin-Converting Enzyme 2IBA 01/2021
1	LipidsIBA 01/2021
1	Biological ProductsIBA 01/2021
1	Hemoglobins (Hemoglobin)IBA 01/2020
1	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2019
1	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 01/2019
1	Dendrimers (Dendrons)IBA 01/2018
1	Everolimus FDA Link 01/2018
1	MTOR InhibitorsIBA 01/2018
1	Immunoglobulin M (IgM)IBA 04/2017
1	Pharmaceutical PreparationsIBA 01/2017
1	Interleukin-8 (Interleukin 8)IBA 01/2017
1	icaritinIBA 01/2016

Therapy/Procedure

9	Peritoneal Dialysis 02/2020 - 12/2003
5	Therapeutics 01/2020 - 12/2012
2	Catheters 01/2012 - 05/2010
1	Ligation 01/2021
1	Kidney Transplantation 01/2018